Literature DB >> 18058831

APOE genotype predicts depression in women with Alzheimer's disease: a retrospective study.

Lisa Delano-Wood1, Wes S Houston, Jennifer A Emond, Natalie L Marchant, David P Salmon, Dilip V Jeste, Leon J Thal, Mark W Bondi.   

Abstract

OBJECTIVE: The association between the APOE epsilon4 allele and depression was investigated in a retrospective study of 323 AD patients.
METHODS: Patients were divided into demographically comparable groups based on the presence or absence of depression.
RESULTS: Results showed that the frequency of APOE epsilon4 allele was significantly higher in the depressed vs non-depressed AD patients (72% and 58%, respectively), and an interaction revealed that women possessing the APOE epsilon4 allele were almost four times more likely to be depressed than those without the epsilon4 allele.
CONCLUSION: Results are consistent with recent suggestions that the APOE epsilon4 genotype may be over-represented among depressed women with AD and highlight the need for additional research investigating the links between APOE genotype, mood, and gender.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18058831      PMCID: PMC2583456          DOI: 10.1002/gps.1953

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  52 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.

Authors:  E H Corder; A M Saunders; W J Strittmatter; D E Schmechel; P C Gaskell; G W Small; A D Roses; J L Haines; M A Pericak-Vance
Journal:  Science       Date:  1993-08-13       Impact factor: 47.728

3.  Association between the APOE genotype and psychopathologic symptoms in Alzheimer's disease.

Authors:  N Scarmeas; J Brandt; M Albert; D P Devanand; K Marder; K Bell; A Ciappa; B Tycko; Y Stern
Journal:  Neurology       Date:  2002-04-23       Impact factor: 9.910

4.  Depressive symptoms, cognitive decline, and risk of AD in older persons.

Authors:  Robert S Wilson; L L Barnes; C F Mendes de Leon; N T Aggarwal; J S Schneider; J Bach; J Pilat; L A Beckett; S E Arnold; D A Evans; D A Bennett
Journal:  Neurology       Date:  2002-08-13       Impact factor: 9.910

5.  Depression in Alzheimer's disease might be associated with apolipoprotein E epsilon 4 allele frequency in women but not in men.

Authors:  Thomas Müller-Thomsen; Sönke Arlt; Stefanie Ganzer; Ulrike Mann; Reinhard Mass; Dieter Naber; Ulrike Beisiegel
Journal:  Dement Geriatr Cogn Disord       Date:  2002       Impact factor: 2.959

6.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

7.  Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease.

Authors:  A M Saunders; W J Strittmatter; D Schmechel; P H George-Hyslop; M A Pericak-Vance; S H Joo; B L Rosi; J F Gusella; D R Crapper-MacLachlan; M J Alberts
Journal:  Neurology       Date:  1993-08       Impact factor: 9.910

8.  Interaction between hypertension, apoE, and cerebral white matter lesions.

Authors:  Frank-Erik de Leeuw; Florence Richard; Jan Cees de Groot; Cornelia M van Duijn; Albert Hofman; Jan Van Gijn; Monique M B Breteler
Journal:  Stroke       Date:  2004-04-01       Impact factor: 7.914

Review 9.  Depression in Alzheimer's disease: overview and treatment.

Authors:  Constantine G Lyketsos; Jason Olin
Journal:  Biol Psychiatry       Date:  2002-08-01       Impact factor: 13.382

Review 10.  Overview of depression and psychosis in Alzheimer's disease.

Authors:  R E Wragg; D V Jeste
Journal:  Am J Psychiatry       Date:  1989-05       Impact factor: 18.112

View more
  15 in total

1.  APOE ϵ4, rated life experiences, and affect among centenarians.

Authors:  Peter Martin; S Michal Jazwinski; Adam Davey; Robert C Green; Maurice Macdonald; Jennifer A Margrett; Ilene C Siegler; Jonathan Arnold; John L Woodard; Mary Ann Johnson; Sangkyu Kim; Jianliang Dai; Li Li; Mark A Batzer; Leonard W Poon
Journal:  Aging Ment Health       Date:  2013-09-02       Impact factor: 3.658

Review 2.  Determinants of behavioral and psychological symptoms of dementia: A scoping review of the evidence.

Authors:  Ann Kolanowski; Marie Boltz; Elizabeth Galik; Laura N Gitlin; Helen C Kales; Barbara Resnick; Kimberly S Van Haitsma; Amy Knehans; Jane E Sutterlin; Justine S Sefcik; Wen Liu; Darina V Petrovsky; Lauren Massimo; Andrea Gilmore-Bykovskyi; Margaret MacAndrew; Glenna Brewster; Vycki Nalls; Ying-Ling Jao; Naomi Duffort; Danny Scerpella
Journal:  Nurs Outlook       Date:  2017-06-16       Impact factor: 3.250

3.  Does Gender Influence the Relationship Between High Blood Pressure and Dementia? Highlighting Areas for Further Investigation.

Authors:  Anna E Blanken; Daniel A Nation
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

4.  Gender differences in presentation and management of behavioral and psychological symptoms associated with dementia among nursing home residents with moderate to severe dementia.

Authors:  Barbara Resnick; Elizabeth Galik; Ann Kolanowski; Kimberly VanHaitsma; Marie Boltz; Shijun Zhu; Jeanette Ellis; Liza Behrens; Karen Eshraghi
Journal:  J Women Aging       Date:  2020-03-06

5.  Associations between stroke risk and cognition in normal aging and Alzheimer's disease with and without depression.

Authors:  Katherine J Bangen; Lisa Delano-Wood; Christina E Wierenga; Ashley McCauley; Dilip V Jeste; David P Salmon; Mark W Bondi
Journal:  Int J Geriatr Psychiatry       Date:  2010-02       Impact factor: 3.485

6.  Neuropsychiatric Symptoms, Endophenotypes, and Syndromes in Late-Onset Alzheimer's Disease: Focus on APOE Gene.

Authors:  Francesco Panza; Davide Seripa; Grazia D'Onofrio; Vincenza Frisardi; Vincenzo Solfrizzi; Patrizia Mecocci; Alberto Pilotto
Journal:  Int J Alzheimers Dis       Date:  2011-04-07

Review 7.  Behavioral and psychological symptoms in Alzheimer's disease.

Authors:  Xiao-Ling Li; Nan Hu; Meng-Shan Tan; Jin-Tai Yu; Lan Tan
Journal:  Biomed Res Int       Date:  2014-07-15       Impact factor: 3.411

Review 8.  The association of antidepressant drug usage with cognitive impairment or dementia, including Alzheimer disease: A systematic review and meta-analysis.

Authors:  John Moraros; Chijioke Nwankwo; Scott B Patten; Darrell D Mousseau
Journal:  Depress Anxiety       Date:  2016-12-28       Impact factor: 6.505

9.  A depressive endophenotype of mild cognitive impairment and Alzheimer's disease.

Authors:  Leigh A Johnson; James R Hall; Sid E O'Bryant
Journal:  PLoS One       Date:  2013-07-11       Impact factor: 3.240

10.  Alzheimer Disease and Selected Risk Factors Disrupt a Co-regulation of Monoamine Oxidase-A/B in the Hippocampus, but Not in the Cortex.

Authors:  Maa O Quartey; Jennifer N K Nyarko; Paul R Pennington; Ryan M Heistad; Paula C Klassen; Glen B Baker; Darrell D Mousseau
Journal:  Front Neurosci       Date:  2018-06-26       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.